Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v6-EN
Language French English
Date Updated 2020-06-10 2017-05-12
Drug Identification Number 02294710 02294710
Brand name PMS-NAPROXEN EC PMS-NAPROXEN EC
Common or Proper name NAPROZEN NAPROZEN
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients NAPROXEN NAPROXEN
Strength(s) 500MG 500MG
Dosage form(s) TABLET (ENTERIC-COATED) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code M01AE M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-12-01 2017-09-28
Actual start date 2017-12-15
Estimated end date Unknown Unknown
Actual end date 2020-06-09
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Product to be discontinued.
Health Canada comments